Who is sponsoring C-VIEW?

C-VIEW is sponsored by UCB Biopharma SRL.

What condition does C-VIEW study?

C-VIEW studies Axial Spondyloarthritis (axSpA), Anterior Uveitis (AU).

What drugs are being tested in C-VIEW?

Interventions: Certolizumab Pegol.

Last reviewed 2021-02-09 · How we verify

A Study to Assess the Effects of Certolizumab Pegol on the Reduction of Anterior Uveitis (AU) Flares in Axial Spondyloarthritis Subjects With a Documented History of AU (C-VIEW)

NCT03020992 PHASE4 COMPLETED Results posted

The purpose of the study is to demonstrate the effect of Certolizumab Pegol (CZP) treatment on the reduction of Anterior Uveitis (AU) flares in subjects with active axial Spondyloarthritis (axSpA) and a documented history of AU.

Details

Lead sponsor	UCB Biopharma SRL
Phase	PHASE4
Status	COMPLETED
Enrolment	89
Start date	Wed Dec 21 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Thu Jan 23 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

Axial Spondyloarthritis (axSpA)
Anterior Uveitis (AU)

Interventions

Certolizumab Pegol

Countries

Netherlands, Germany, Poland, Spain, Czechia